Table 1.
Clinical data | EGFR statusa on tissue sections | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Case no. | Sex | Age (years) | pTNM | Location | Neoadjuvant treatment | Primary site | Synchronous metastases (location number) | Metachronous metastases (location number) | |||||||
1 | 2 | 3 | 4 | 1 | 2 | 3 | 4 | 5 | |||||||
1 | M | 60 | T3N1M1 | C | + | + | + | + | + | ||||||
2 | M | 60 | T3N2M1 | R | RCT | + | + | + | + | ||||||
3 | M | 66 | T2N0M1 | R | + | + | + | + | |||||||
4 | M | 49 | T3N2M1 | R | CT | + | + | + | + | + | + | + | + | ||
5 | M | 70 | T3N1M1 | C | + | + | + | ||||||||
6 | F | 74 | T3N1M1 | R | RCT | + | + | + | |||||||
7 | F | 59 | T3N2M1 | R | CT | + | + | + | − | ||||||
8 | M | 71 | T3N2M1 | C | + | + | + | ||||||||
9 | F | 55 | T3N2M1 | R | − | + | − | ||||||||
10 | F | 61 | T4N1M1 | C | CT | + | + | + | |||||||
11 | F | 68 | T3N1M1 | C | CT | + | + | + | |||||||
12 | M | 75 | T3N1M1 | R | + | + | |||||||||
13 | M | 72 | T3N1M1 | C | + | + | |||||||||
14 | M | 54 | T3N0M1 | C | + | + | |||||||||
15 | F | 55 | T4N1M1 | C | + | + | |||||||||
16 | F | 57 | T4N2M1 | C | + | + | |||||||||
17 | F | 52 | T3N1M1 | R | + | + | |||||||||
18 | M | 53 | T3N0M1 | C | + | + | |||||||||
19 | M | 62 | T4N2M1 | C | + | + | |||||||||
20 | F | 77 | T3N2M1 | C | + | + | |||||||||
21 | F | 49 | T3N1M1 | C | + | + | |||||||||
22 | F | 51 | T3N2M1 | C | + | + | |||||||||
23 | M | 62 | T3N2M1 | R | RT | + | + | ||||||||
24 | F | 65 | T3N1M1 | C | CT | + | + | ||||||||
25 | M | 56 | T4N1M1 | C | CT | + | + | ||||||||
26 | F | 47 | T3N1M1 | R | RT | + | + | ||||||||
27 | F | 59 | T3N1M1 | C | + | − | |||||||||
28 | F | 45 | T3N2M1 | C | + | − | |||||||||
29 | F | 81 | T3N1M1 | R | − | + | |||||||||
30 | M | 58 | T2N0M1 | C | − | + | |||||||||
31 | M | 69 | T3N1M1 | C | − | + | |||||||||
32 | F | 68 | T3N2M1 | C | − | + |
Liver metastases in all cases except for a metachronous pulmonary metastasis and a synchronous ovarian metastasis in patients 7 and 15, respectively
C colon, R rectum, RCT radio-chemotherapy, CT chemotherapy before surgical resection of metastasis, RT radiotherapy
aPositive if >1% of tumor cells expressed EGFR